BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 6291922)

  • 21. Pituitary gonadotropin-releasing hormone (GnRH) receptor responses to GnRH in hypothalamus-lesioned rats: inhibition of responses by hyperprolactinemia and evidence that testosterone and estradiol modulate gonadotropin secretion at postreceptor sites.
    Pieper DR; Gala RR; Schiff MA; Regiani SR; Marshall JC
    Endocrinology; 1984 Sep; 115(3):1190-6. PubMed ID: 6086288
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dopamine is not involved in the opioid control of luteinizing hormone secretion in man.
    Foresta C; Indino M; Federspil G; Scandellari C
    Fertil Steril; 1985 Oct; 44(4):504-7. PubMed ID: 4054321
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hypothalamic LH-releasing activity in young and aged intact and gonadectomized rats.
    Miller AE; Riegle GD
    Exp Aging Res; 1978 Jun; 4(3):145-55. PubMed ID: 679966
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of a sustained-release naloxone pellet on luteinizing hormone secretion in female rats.
    Gabriel SM; Simpkins JW
    Neuroendocrinology; 1983 Nov; 37(5):342-8. PubMed ID: 6139759
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The opioid control of LH and FSH release: effects of a met-enkephalin analogue and naloxone.
    Grossman A; Moult PJ; Gaillard RC; Delitala G; Toff WD; Rees LH; Besser GM
    Clin Endocrinol (Oxf); 1981 Jan; 14(1):41-7. PubMed ID: 6784982
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Possible involvement of gamma-aminobutyric acid in growth hormone release induced by a Met5-enkephalin analog in conscious rats.
    Katakami H; Kato Y; Matsushita N; Shimatsu A; Imura H
    Endocrinology; 1981 Oct; 109(4):1033-6. PubMed ID: 7285858
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Relative effectiveness of naloxone and MR2266 in potentiating oestrogen-stimulated luteinizing hormone surges in ovariectomized female rats.
    Dyer RG; Mansfield S; Dean AD
    Neurosci Lett; 1984 Aug; 49(1-2):111-5. PubMed ID: 6093001
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Desensitization of brain opiate receptor mechanisms by gonadal steroid treatments that stimulate luteinizing hormone secretion.
    Berglund LA; Derendorf H; Simpkins JW
    Endocrinology; 1988 Jun; 122(6):2718-26. PubMed ID: 2836173
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mainly mu-opiate receptors are involved in luteinizing hormone and prolactin secretion.
    Panerai AE; Petraglia F; Sacerdote P; Genazzani AR
    Endocrinology; 1985 Sep; 117(3):1096-9. PubMed ID: 2990867
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hypothalamic opioid mechanisms in experimental uremic hypogonadism.
    Dong QH; Handelsman DJ
    Endocrinology; 1990 Mar; 126(3):1498-503. PubMed ID: 2137774
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of gonadectomy and treatment with gonadal steroids and luteinizing hormone secretion in hypogonadal male and female mice with preoptic area implants.
    Gibson MJ; Silverman AJ
    Endocrinology; 1989 Sep; 125(3):1525-32. PubMed ID: 2759032
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of gonadectomy on the in vitro and in vivo gonadotropin responses to gonadotropin-releasing hormone in male and female rats.
    Fallest PC; Hiatt ES; Schwartz NB
    Endocrinology; 1989 Mar; 124(3):1370-9. PubMed ID: 2492928
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of a met-enkephalin analog on adrenocorticotropin (ACTH), growth hormone, and prolactin in patients with ACTH hypersecretion.
    Allolio B; Winkelmann W; Hipp FX; Kaulen D; Mies R
    J Clin Endocrinol Metab; 1982 Jul; 55(1):1-7. PubMed ID: 6281297
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Discriminative effects of testosterone on hypothalamic luteinizing hormone-releasing hormone levels and luteinizing hormone secretion in castrated male rats: analyses of dose and duration characteristics.
    Kalra PS; Kalra SP
    Endocrinology; 1982 Jul; 111(1):24-9. PubMed ID: 7044762
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sex-dependent endorphinergic and adrenergic control mechanisms of luteinizing hormone secretion in immature rats.
    Schulz R; Wilhelm A; Pirke KM; Herz A
    Acta Endocrinol (Copenh); 1985 Jun; 109(2):198-203. PubMed ID: 2990132
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Opioid inhibition of luteinizing hormone secretion compared in developing male and female sheep.
    Wood RI; I'Anson H; Ebling FJ; Foster DL
    Neuroendocrinology; 1992 Dec; 56(6):822-30. PubMed ID: 1369590
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Naloxone does not reverse the inhibitory effect of morphine on luteinizing hormone secretion in prepubescent male rats.
    Cicero TJ; Nock B; O'Connor L
    J Pharmacol Exp Ther; 1993 Jan; 264(1):47-53. PubMed ID: 8380870
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neuropharmacological analysis of the control of LH secretion in gonadectomized male and female rats: altered hypothalamic responses to inhibitory neurotransmitters in long-term castrated rats.
    Almeida OF; Nikolarakis KE; Herz A
    J Endocrinol; 1988 Oct; 119(1):15-21. PubMed ID: 2903898
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of testosterone implants and hypothalamic lesions on luteinizing hormone regulation in the castrated male rat.
    Cheung CY; Davidson JM
    Endocrinology; 1977 Feb; 100(2):292-302. PubMed ID: 318993
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of exogenous and endogenous opiates on the hypothalamic--pituitary--gonadal axis in the male.
    Cicero TJ
    Fed Proc; 1980 Jun; 39(8):2551-4. PubMed ID: 6247215
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.